Innovations in Personalized Oncology: A Case-Based Approach

Research advances are leading at an unprecedented rate to opportunities for greater personalization of management approaches for patients with cancer and the promise of related improvements in disease-control and patient-reported outcomes. A challenge facing clinical practitioners, oncology care teams and healthcare systems is the identification and timely integration of these important innovations, often developed at specialty centers, into day-to-day clinical practice in the community setting and closer to where patients live.

A central goal of this CME course is to help busy oncologists and other oncology care team members acquire clinically-relevant, cutting-edge knowledge and translate these innovations into best practices, using lessons learned within the MSK Cancer Alliance and highlighting the personalized approach to cancer care taken by MSK and its Alliance Members. 

Incorporating a case-based format that utilizes real-life, clinical scenarios, the moderator of each multidisciplinary expert panel will use audience response to examine key decision points and guide targeted commentary and presentations from panel members that include oncologists and other oncology care team members. 

Panels will cover eight different diseases, both rare and more common, and address a spectrum of management issues across the care continuum. Immunotherapy, from evolving predictors of response to symptom management for these new agents, will be the focus of two keynote talks. After this course, attendees will be better able to tailor care to meet the unique needs of their patients and appreciate the role of dynamic partnerships among providers to optimally personalize and improve outcomes of cancer care.

Target audience

The target audience for this course includes physicians, advanced practice providers, nurses, allied health professionals and administrators looking for innovative, disease-specific oncology content set within multidisciplinary case discussions.

3rd Annual MSK Cancer Alliance Symposium

The MSK Cancer Alliance is a collaborative relationship, leveraging bi-directional learning for mutual improvement. It is composed of MSK and a small number of high-quality, community healthcare systems seeking to be centers of excellence in their respective communities with a focus on clinical research and a culture of improvement. The MSK Cancer Alliance strives to bridge the knowledge gaps between an academic comprehensive cancer center such as MSK and community hospitals in order to help facilitate the delivery of high-quality cancer care at the community level, an important need since most cancer care is delivered in the community setting. Discounted rate available for MSK Alliance members - please see details below. 

Please note: Providers outside of the MSK Cancer Alliance are encouraged to attend this symposium. 

1. Evaluate the potential utility of the covered developments and advances in current oncology practice.
2. Outline and evaluate the supporting evidence for these developments and advances.
3. Appreciate the appropriate clinical settings to apply the reviewed technologies and therapies.
4. Incorporate appropriately these novel strategies into patient care.
5. Understand how Alliance relationships can facilitate bi-directional learning and improve outcomes of care.

*Industry professionals may attend CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Registration includes continental breakfast, lunch, and refreshment breaks. Please contact us at least one week prior to the course if you have any special dietary needs.

• Discounted Rate for MSK Alliance Members - MSK offers a discounted rate to all MSK Alliance members to attend a CME course. Please contact [email protected] for more information or a promotion code. 
• 30% Discounted Rate for MSK Alumni - Please contact [email protected] for more information or a promotion code. 
• MSK Staff Registration - Registration is complimentary for MSK staff. However, you must complete course registration to attend this course.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Memorial Sloan Kettering Cancer Center, Hartford Healthcare Cancer Institute, Lehigh Valley Health Network, and Miami Cancer Institute of Baptist Health South Florida. Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 7 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.00 Medical Knowledge and Practice Assessment MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit

If you’ll be traveling to MSK from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, we’ve negotiated special rates and amenities for patients, families, and caregivers at select hotels in Manhattan.

The Kimberly Hotel
 
145 East 50th Street
(Between Lexington and Third Avenues)
New York, NY 10022

Reservations: (800) 683-0400 | www.kimberlyhotel.com

A newly renovated luxury hotel and 2013 winner of best in the business class by Conde Nast and best in VIP services by Expedia, the Kimberly Hotel is located in the heart of midtown, two short blocks from the shuttle to Memorial Sloan Kettering’s facilities. Known for impeccable service, attention to detail, oversize guest rooms, and suites with balconies — some with living rooms offering sofa beds with Simmons mattresses — the hotel is equipped with wet bars, microwaves, luxury amenities, elevated electronics available upon request, and a famous rooftop lounge, called Upstairs, that’s open year-round for a full American breakfast and late-night dining.  Visit their famous American-fusion Opera House, Noir, and receive 20 percent off on menu items and two complimentary drinks per stay (open for lunch, dinner, and late-night dining).

Courtyard New York Manhattan/Midtown East
 
866 Third Avenue
(Between 52nd and 53rd Streets)
New York, NY 10022

Reservations: (800) 321-2211 | website  

This recently renovated hotel is located in the same building as our Rockefeller Outpatient Pavilion at 160 East 53rd Street. Memorial Sloan Kettering offers shuttle service from the Rockefeller Outpatient Pavilion to our main campus at 1275 York Avenue, running every 20 minutes, Monday to Friday, 7:30 am to 6:20 pm. The hotel offers some of the largest rooms in New York City, beginning at 420 square feet, with complimentary Internet access and refrigerators in every room. The restaurant, Table 866 serves a variety of refreshing breakfast options and drinks with Starbucks® coffee. The hotel is steps from subway transportation.

For additional hotels in the area with negotiated special rates, please visit: www.mskcc.org/accommodations

MSK Course Director

David G. Pfister, MD
Associate Deputy Physician-in-Chief, Strategic Partnerships
Chief, Head and Neck Oncology
Attending Physician
Department of Medicine
Memorial Sloan Kettering Cancer Center

Course Co-Directors

Steven Jon Shichman, MD
Physician in Chief
Tallwood Urology and Kidney Institute
Hartford Healthcare Cancer Institute

Usman Shah, MD
Assistant Medical Director
Lehigh Valley Health Network Cancer Institute

Starr Mautner, MD
Breast Surgical Oncologist
Miami Cancer Institute

Invited Faculty

Mario Katigbak, MD
Division Chief of Thoracic Surgery
Hartford Healthcare

Peter Yu, MD
Physician-in-Chief
Hartford HealthCare Cancer Institute

Martin Martino, MD
Medical Director
Minimally Invasive Robotic Surgery
Lehigh Valley Health Network

John S. Park, MD
Associate Program Director, 
LVHN Colorectal Surgery Fellowship
Lehigh Valley Health Network

Marcio Fagundes, MD
Attending Radiation Oncologist
Miami Cancer Institute

Matthew Hall, MD
Attending Radiation Oncologist
Miami Cancer Institute

MSK Faculty

Smita Banerjee, PhD
Assistant Attending Behavioral Scientist
Department of Psychiatry & Behavioral Services

Connie Batlevi, MD, PhD
Assistant Attending Physician
Lymphoma Service
Department of Medicine

Kevin C. De Braganca, MD
Associate Program Director
Pediatric Neuro-Oncology Fellowship
Assistant Attending Pediatrician
Pediatric Neuro-Oncology Service
Department of Pediatrics

Timothy Chan, MD, PhD
Vice Chair, Department of Radiation Oncology
Director, Translational Oncology Division
Director, Immunogenomics and Precision Oncology Platform
PaineWebber Chair in Cancer Genetics 
Member, Human Oncology & Pathogenesis Program 
Attending Physician
Department of Radiation Oncology

Jason Carter, PA-C
Physician Assistant, Clinical Research
Department of Medicine

Andrea Cercek, MD
Assistant Attending Physician
Gastrointestinal Oncology Service
Department of Medicine

Lawrence Dauer, PhD
Clinical Physicist, Radiation Safety Manager 
Chair, Emergency Management Committee
Radiochemistry and Imaging Sciences Service
Department of Medical Physics
Department of Radiology

James Eastham, MD
Chief, Urology Service
Peter T. Scardino Chair in Oncology
Attending Surgeon
Department of Surgery

Lauren Evans, MSN, OCN, CCRP
Clinical Trials Nurse Coordinator
Department of Nursing

Ginger Gardner, MD
Physician Lead
Alliance Gynecology Disease Management Team
Associate Attending Physician
Gynecology Service
Department of Surgery

Ruth-Ann Gordon, MSN, FNP-BC, OCN
Clinical Trials Nurse Coordinator
Department of Nursing

Alan Ho, MD
Geoffrey Beene Junior Faculty Chair
Assistant Attending Physician
Head and Neck Oncology Service
Department of Medicine

Philip Kantoff, MD
Chair, Department of Medicine
George J. Bosl Chair
Attending Physician
Genitourinary Oncology Service
Department of Medicine

Bob Li, MD, MPH
Assistant Attending Physician
Thoracic Oncology Service,
Developmental Therapeutics
Department of Medicine

Sean McBride, MD, MPH
Assistant Attending Radiation Oncologist
Department of Radiation Oncology

Elizabeth Morris, MD
Chief, Breast Imaging Service
Larry Norton Chair
Attending Radiologist
Department of Radiology

Michael Morris, MD
Associate Attending Physician
Genitourinary Oncology Service
Department of Medicine

Alison J. Moskowitz, MD
Assistant Attending Medical Oncologist
Clinical Director, Lymphoma Inpatient Unit
Department of Medicine

Larry Norton, MD
Deputy Physician-in-Chief, Breast Cancer Programs
Medical Director, Evelyn H. Lauder Breast Center
Norna S. Sarofim Chair in Clinical Oncology
Attending Physician
Breast Medicine Service
Department of Medicine

Roisin E. O’Cearbhaill, MD
Assistant Attending Physician
Gynecologic Medical Oncology Service
Department of Medicine

Bernard Park, MD
Deputy Chief of Clinical Affairs, Thoracic Service
Attending Surgeon
Surgical Director, Alliance Programs 
Department of Surgery

Melissa Pilewskie, MD
Assistant Attending Surgeon
Breast Service
Department of Surgery

Marc Rosenblum, MD
Chief, Autopsy Service
Director, Neuropathology
Founder’s Chair
Attending Pathologist
Department of Pathology

Mikel Ross, BSN, RN, OCN, CBCN
Office Practice Nurse, 
Outpatient Breast Medicine Service
Department of Nursing

Paul Sabbatini, MD
Deputy Physician-In-Chief, Clinical Research
Attending Physician
Gynecologic Medical Oncology Service
Department of Medicine

Mona Sabra, MD
Attending Physician
Endocrinology Service
Department of Medicine

Leonard B. Saltz, MD
Executive Director, Clinical Value and Sustainability
Attending Physician
Gastrointestinal Oncology Service
Department of Medicine

Stephen Sands, PsyD
Director, Pediatric Neuropsychology
Attending Psychologist
Psychiatry Service
Department of Pediatrics

Jesse Joshua Smith, MD, PhD
Assistant Attending Surgeon
Colorectal Service
Department of Surgery

William P. Tew, MD
Associate Attending Physician
Gynecologic Medical Oncology Service
Department of Medicine

John Timoney, Pharm D
Assistant Director, Pharmacy
MSKCC, Basking Ridge

Tiffany A. Traina, MD
Associate Attending Physician
Breast Medicine Service
Department of Medicine

Michael Tuttle, MD
Attending Physician
Endocrinology Service
Department of Medicine

Suzanne L. Wolden, MD
Attending Radiation Oncologist
Radiation Oncology Director, Alliance Programs
External Beam Radiotherapy Service
Brachytherapy Service
Department of Radiation Oncology

Rona D. Yaeger, MD
Assistant Attending Physician
Gastrointestinal Oncology Service
Department of Medicine

Helena A. Yu, MD
Assistant Attending Physician
Thoracic Oncology Service
Department of Medicine

Andrew D. Zelenetz, MD, PhD
Medical Director, Quality Informatics 
Attending Physician
Lymphoma Service
Division of Hematologic Oncology
Department of Medicine

Friday, May 4, 2018